Clínica Baviera Past Earnings Performance
Past criteria checks 4/6
Clínica Baviera has been growing earnings at an average annual rate of 13.3%, while the Healthcare industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 15.4% per year. Clínica Baviera's return on equity is 38.7%, and it has net margins of 13.8%.
Key information
13.31%
Earnings growth rate
13.47%
EPS growth rate
| Healthcare Industry Growth | 13.41% |
| Revenue growth rate | 15.40% |
| Return on equity | 38.70% |
| Net Margin | 13.80% |
| Last Earnings Update | 31 Dec 2025 |
Recent past performance updates
Recent updates
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Baviera: Europe's Most Capital-Efficient Eye Care Compounder — Trading at Distressed Multiples While Delivering 15% CAGR and 40% ROCE. Fair Value €88/share ### The Business Clínica Baviera is Europe's leading specialist ophthalmology clinic network, focused on laser vision correction and intraocular surgery.We Think Clínica Baviera (BME:CBAV) Can Manage Its Debt With Ease
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...A Piece Of The Puzzle Missing From Clínica Baviera, S.A.'s (BME:CBAV) Share Price
With a price-to-earnings (or "P/E") ratio of 13x Clínica Baviera, S.A. ( BME:CBAV ) may be sending bullish signals at...Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings
Clínica Baviera, S.A.'s ( BME:CBAV ) price-to-earnings (or "P/E") ratio of 14.5x might make it look like a buy right...Clínica Baviera (BME:CBAV) Might Become A Compounding Machine
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405
The board of Clínica Baviera, S.A. ( BME:CBAV ) has announced that it will pay a dividend of €0.405 per share on the...Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that Clínica Baviera's (BME:CBAV) stock increased significantly by 28% over the...Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return
It might be of some concern to shareholders to see the Clínica Baviera, S.A. ( BME:CBAV ) share price down 16% in the...Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Revenue & Expenses Breakdown
How Clínica Baviera makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 305 | 42 | 18 | 0 |
| 30 Sep 25 | 297 | 40 | 14 | 0 |
| 30 Jun 25 | 289 | 39 | 14 | 0 |
| 31 Mar 25 | 280 | 41 | 0 | 0 |
| 31 Dec 24 | 266 | 40 | 14 | 0 |
| 30 Sep 24 | 252 | 37 | 12 | 0 |
| 30 Jun 24 | 243 | 38 | 12 | 0 |
| 31 Mar 24 | 234 | 37 | 12 | 0 |
| 31 Dec 23 | 227 | 36 | 12 | 0 |
| 30 Sep 23 | 217 | 32 | 0 | 0 |
| 30 Jun 23 | 212 | 31 | 12 | 0 |
| 31 Mar 23 | 205 | 30 | 12 | 0 |
| 31 Dec 22 | 198 | 30 | 12 | 0 |
| 30 Sep 22 | 193 | 30 | 10 | 0 |
| 30 Jun 22 | 189 | 30 | 10 | 0 |
| 31 Mar 22 | 184 | 31 | 10 | 0 |
| 31 Dec 21 | 173 | 27 | 10 | 0 |
| 30 Sep 21 | 165 | 28 | 8 | 0 |
| 30 Jun 21 | 160 | 27 | 8 | 0 |
| 31 Mar 21 | 134 | 20 | 8 | 0 |
| 31 Dec 20 | 123 | 14 | 8 | 0 |
| 30 Sep 20 | 117 | 12 | 9 | 0 |
| 30 Jun 20 | 112 | 9 | 9 | 0 |
| 31 Mar 20 | 124 | 11 | 0 | 0 |
| 31 Dec 19 | 124 | 13 | 9 | 0 |
| 30 Sep 19 | 119 | 12 | 15 | 0 |
| 30 Jun 19 | 115 | 12 | 15 | 0 |
| 31 Mar 19 | 110 | 12 | 15 | 0 |
| 31 Dec 18 | 109 | 12 | 15 | 0 |
| 30 Sep 18 | 107 | 11 | 15 | 0 |
| 30 Jun 18 | 106 | 12 | 15 | 0 |
| 31 Mar 18 | 104 | 11 | 15 | 0 |
| 31 Dec 17 | 100 | 10 | 15 | 0 |
| 30 Sep 17 | 97 | 8 | 13 | 0 |
| 30 Jun 17 | 94 | 8 | 13 | 0 |
| 31 Mar 17 | 92 | 8 | 13 | 0 |
| 31 Dec 16 | 92 | 8 | 13 | 0 |
| 30 Sep 16 | 92 | 9 | 13 | 0 |
| 30 Jun 16 | 91 | 8 | 13 | 0 |
| 31 Mar 16 | 88 | 6 | 13 | 0 |
| 31 Dec 15 | 86 | 5 | 13 | 0 |
| 30 Sep 15 | 84 | 4 | 13 | 0 |
| 30 Jun 15 | 83 | 4 | 13 | 0 |
Quality Earnings: CBAV has high quality earnings.
Growing Profit Margin: CBAV's current net profit margins (13.8%) are lower than last year (15.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBAV's earnings have grown by 13.3% per year over the past 5 years.
Accelerating Growth: CBAV's earnings growth over the past year (4.6%) is below its 5-year average (13.3% per year).
Earnings vs Industry: CBAV earnings growth over the past year (4.6%) exceeded the Healthcare industry 4.6%.
Return on Equity
High ROE: CBAV's Return on Equity (38.7%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/24 12:48 |
| End of Day Share Price | 2026/06/24 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clínica Baviera, S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| León Izuzquiza Lenze | Banco de Sabadell. S.A. |
| Marta Diaz | Banco de Sabadell. S.A. |
| Bosco Muguiro Eulate | Banco Santander |